Cardiovascular and Hematological Disorders - Drug Targets : Impact Factor & More
eISSN: 2212-4063pISSN: 1871-529X
Share this on:
Key Metrics
CiteScore 
2.6
SNIP
0.4
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Cardiovascular and Hematological Disorders - Drug Targets Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Frequency | Semi-annual |
| General Details |
View less
Planning to publish in Cardiovascular and Hematological Disorders - Drug Targets ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cardiovascular and Hematological Disorders - Drug Targets
Effective Lowering of Lipoprotein (a) - A New Frontier in Cardiovascular Risk Reduction.
- 30 Jun 2026
- Cardiovascular & hematological disorders drug targets
Innovations in Hemorrhage Management: Calcium Alginate, Celox, and Desmopressin as Next-generation Hemostatic Agents.
- 12 Jun 2026
- Cardiovascular & hematological disorders drug targets
Plant-Derived Therapeutics for Androgen Deficiency Syndrome.
- 21 May 2026
- Cardiovascular & hematological disorders drug targets
Zerlasiran for Lipoprotein(a) Reduction: Mechanisms, Evidence, and Future Directions.
- 12 May 2026
- Cardiovascular & hematological disorders drug targets
The Role of Retinoid X Receptor Signaling in Multi-organ Ischemia/Reperfusion Injury: A Comprehensive Review.
- 6 May 2026
- Cardiovascular & hematological disorders drug targets
Targeting Hyperlipidemia: Investigating the Regulatory Roles of NPC1L1 and SREBP-2 and the Therapeutic Potential of Bioactive Compounds.
- 6 May 2026
- Cardiovascular & hematological disorders drug targets
Effective Lowering of Lipoprotein (a) - A New Frontier in Cardiovascular Risk Reduction.
- 30 Jun 2026
- Cardiovascular & hematological disorders drug targets
Innovations in Hemorrhage Management: Calcium Alginate, Celox, and Desmopressin as Next-generation Hemostatic Agents.
- 12 Jun 2026
- Cardiovascular & hematological disorders drug targets
Plant-Derived Therapeutics for Androgen Deficiency Syndrome.
- 21 May 2026
- Cardiovascular & hematological disorders drug targets
Zerlasiran for Lipoprotein(a) Reduction: Mechanisms, Evidence, and Future Directions.
- 12 May 2026
- Cardiovascular & hematological disorders drug targets
The Role of Retinoid X Receptor Signaling in Multi-organ Ischemia/Reperfusion Injury: A Comprehensive Review.
- 6 May 2026
- Cardiovascular & hematological disorders drug targets
Targeting Hyperlipidemia: Investigating the Regulatory Roles of NPC1L1 and SREBP-2 and the Therapeutic Potential of Bioactive Compounds.
- 6 May 2026
- Cardiovascular & hematological disorders drug targets
FAQs on Cardiovascular and Hematological Disorders - Drug Targets
What is the publishing frequency of Cardiovascular and Hematological Disorders - Drug Targets? 
How many articles did Cardiovascular and Hematological Disorders - Drug Targets publish last year?
What is the eISSN & pISSN for Cardiovascular and Hematological Disorders - Drug Targets?
What is Citescore for Cardiovascular and Hematological Disorders - Drug Targets?
What is SNIP score for Cardiovascular and Hematological Disorders - Drug Targets?
Who is the publisher of Cardiovascular and Hematological Disorders - Drug Targets?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations